European Healthcare regulators take a hard look at CE Mark loopholes that allow medical device companies to “shop” for easier pathways to approval.
MASSDEVICE ON CALL — Under fire for being too lenient with medical device approvals, European regulators proposed an update to current CE Mark review and approval practices.
Specifically, the European Commission's proposed changes address the relative ease with which companies can secure CE Mark approval by "shopping" for an agency in a specific country that will most quickly green-light a new device.
The new proposal would scrutinize private companies that currently help guide approvals, homogenize the approval process among countries and increase pre-market information transparency between countries, according to QMed.
Magnetic stimulation might "completely" treat depression
Data from a London Psychiatry Center study concluded that 6 out of 10 of patients with serious, treatment-resistant depression recovered "completely," achieving complete remission after being treated with a repetitive transcranial magnetic stimulation (rTMS).
Edwards Lifesciences CEO Michael Mussallem says the company now expects the FDA to approve its next-...
Reva Medical begins enrolling patients in Europe for a trial of its Fantom bioresorbable stent.
A subcommittee of the U.S. Senate's powerful Finance Committee holds a hearing on the medical device...
Zimmer Holdings and Biomet find a buyer for the knee and elbow assets they pledged to divest to...